| pubmed-article:20086063 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20086063 | lifeskim:mentions | umls-concept:C0085542 | lld:lifeskim |
| pubmed-article:20086063 | lifeskim:mentions | umls-concept:C0132555 | lld:lifeskim |
| pubmed-article:20086063 | lifeskim:mentions | umls-concept:C0243026 | lld:lifeskim |
| pubmed-article:20086063 | lifeskim:mentions | umls-concept:C1515999 | lld:lifeskim |
| pubmed-article:20086063 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:20086063 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20086063 | pubmed:dateCreated | 2010-1-20 | lld:pubmed |
| pubmed-article:20086063 | pubmed:abstractText | Sepsis induces microvascular inflammation and production of the vasodilator nitric oxide (NO) via endothelial and inducible nitric oxide synthase (eNOS or NOS III and iNOS or NOS II). Statins are cholesterol-lowering drugs; however, they also attenuate inflammation. This study aimed to determine whether pravastatin protected against sepsis-induced hypotension, loss of vascular tone, and microvascular inflammation via NOS pathways. | lld:pubmed |
| pubmed-article:20086063 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20086063 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20086063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20086063 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20086063 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:20086063 | pubmed:issn | 1471-6771 | lld:pubmed |
| pubmed-article:20086063 | pubmed:author | pubmed-author:BrownN JNJ | lld:pubmed |
| pubmed-article:20086063 | pubmed:author | pubmed-author:HellewellP... | lld:pubmed |
| pubmed-article:20086063 | pubmed:author | pubmed-author:ReillyC SCS | lld:pubmed |
| pubmed-article:20086063 | pubmed:author | pubmed-author:BrookesZ L... | lld:pubmed |
| pubmed-article:20086063 | pubmed:author | pubmed-author:McGownC CCC | lld:pubmed |
| pubmed-article:20086063 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20086063 | pubmed:volume | 104 | lld:pubmed |
| pubmed-article:20086063 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20086063 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20086063 | pubmed:pagination | 183-90 | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:meshHeading | pubmed-meshheading:20086063... | lld:pubmed |
| pubmed-article:20086063 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20086063 | pubmed:articleTitle | Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. | lld:pubmed |
| pubmed-article:20086063 | pubmed:affiliation | Microcirculation Research Group, Department of Cardiovascular Sciences, University of Sheffield, Faculty of Medicine, Dentistry and Health, Beech Hill Road, Sheffield S10 2RX, UK. | lld:pubmed |
| pubmed-article:20086063 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20086063 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20086063 | lld:pubmed |
